Diabetes mellitus and tuberculosis: Programmatic management issues

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 8, 2015, Pages 879-886

  Harries, A D ^a,b   Kumar, A M V ^c   Satyanarayana, S ^c   Lin, Y ^d   Zachariah, R ^e   Lonnroth K ^f,g   Kapur, A ^h  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c South East Asia Regional Office   (India)

^d Dongwai Diplomatic Building   (China)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g KAROLINSKA INSTITUTE   (Sweden)

^h World Diabetes Foundation   (Denmark)

Author keywords

Bi directional screening; DM; DM TB interaction; Programmatic challenges; TB

Indexed keywords

ETHAMBUTOL; HEMOGLOBIN A1C; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; SULFONYLUREA DERIVATIVE;

BACTERIAL TRANSMISSION; BANGLADESH; CHINA; COHORT ANALYSIS; CONGO; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; GLUCOSE BLOOD LEVEL; HEALTH CARE POLICY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INDIA; INDONESIA; INFECTION CONTROL; LATENT TUBERCULOSIS; LIFESTYLE MODIFICATION; MYANMAR; MYCOBACTERIUM TUBERCULOSIS; ORAL GLUCOSE TOLERANCE TEST; PAKISTAN; PATIENT CARE; PHILIPPINES; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAPID TEST; REVIEW; RUSSIAN FEDERATION; SCREENING; SOUTH AFRICA; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; COOPERATION; HEALTH; MANAGEMENT; MASS SCREENING; PROCEDURES;

COOPERATIVE BEHAVIOR; DIABETES MELLITUS; GLOBAL HEALTH; HEALTH POLICY; HUMANS; MASS SCREENING; POLICY MAKING; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 84938238875     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0069     Document Type: Review

References (41)

1. Stevenson C R, Critchley J A, Forouhi N G, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health. Chronic Illness 2007; 3: 228-245.
2. Jeon C Y, Murray M B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLOS MED 2008; 5: e152.
3. Dooley K E, Chaisson R E. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9: 737-746.
4. Ruslami R, Aarnoutse R E, Alisjahbana B, van der Ven A J A M, van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health 2010; 15: 1289-1299.
5. Riza A L, Pearson F, Ugarte-Gil C, et al. Diabetes and tuberculosis. 2: Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2014; 2: 740-753.
6. Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology 2015; 144: 171-185.
7. Lönnroth K, RoglicG,Harries AD.Diabetes and tuberculosis. 1: Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabetes Endocrinol 2014; 2: 730-739.
8. BakerMA, Harries A D, Jeon C Y, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011; 9: 81.
9. Jimenez-CoronaME, Cruz-Hervert L P, Garcia-Garcia L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 2013; 68: 214-220.
10. World Health Organization and the International Union Against Tuberculosis and Lung Disease. Collaborative Framework for Care and Control of Tuberculosis and Diabetes. WHO/HTM/TB/2011.15. Geneva, Switzerland: WHO, 2011.
11. Jeon C Y, Harries A D, Baker M A, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 2010: 15: 1300-1314.
12. India Tuberculosis-Diabetes Study Group. Screening of patients with tuberculosis for diabetes mellitus in India. Trop Med Int Health 2013; 18: 636-645.
13. Gupta S, Shenoy V P, Bairy I, Srinivasa H, Mukhopadhyay C. Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India. J Infect Public Health 2011; 4: 140-144.
14. Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLOS ONE 2012; 7: e46502.
15. Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLOS ONE 2012; 7: e41367.
16. Codlin A, Nadeem A, Lotia I, et al. Diabetes, pre-diabetes and tuberculosis in an Asian mega-city-Karachi, Pakistan. Int J Tuberc Lung Dis 2012; 16 (Suppl 1): S338-S339.
17. Li L, Lin Y, Mi F, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health 2012; 17: 1294-1301.
18. Wang Q, Ma A, Han X, et al. Prevalence of type 2 diabetes among newly detected pulmonary tuberculosis patients in China: a community based cohort study. PLOS ONE 2013; 8: e82660.
19. Restrepo B I, Camerlin A J, RahbarM H, et al. Cross-sectional assessment reveals high diabetes prevalence among newlydiagnosed tuberculosis cases. Bull World Health Organ 2011; 89: 352-359.
20. Suwanpimolkul G, Grinsdale J A, Jarlsberg L G, et al. Association between diabetes mellitus and tuberculosis in United States-born and foreign-born populations in San Francisco. PLOS ONE 2014; 9: e114442.
21. Faurholt-Jepsen D, Range N, PrayGod G, et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLOS ONE 2011; 6: e24215.
22. Ogbera A O, Kapur A, Chinenye S, Fasanmade O, Uloko A, Odeyemi K. Undiagnosed diabetes mellitus in tuberculosis: a Lagos report. Indian J Endocrinol Metab 2014; 18: 475-479.
23. Nasa J N, Brostrom R, Ram S, et al. Screening adult tuberculosis patients for diabetes mellitus in Ebeye, Republic of the Marshall Islands. Public Health Action 2014; 4 (Suppl 2): S50-S52.
24. Leegaard A, Riis A, Kornum J B, et al. Diabetes, glycemic control, and risk of tuberculosis: a population-based casecontrol study. Diabetes Care 2011; 34: 2530-2535.
25. Dave P, Shah A, Chuahan M, et al. Screening patients with tuberculosis for diabetes mellitus in Gujarat, India. Public Health Action 2013; 3 (Suppl 1): S29-S33.
26. Naik B, Kumar A M V, Satyanarayana S, et al. Is screening for diabetes among tuberculosis patients feasible at the field level? Public Health Action 2013; 3 (Suppl 1): S34-S37.
27. Nair S, Kumari A K, Subramonianpillai J, et al. High prevalence of undiagnosed diabetes among tuberculosis patients in peripheral health facilities in Kerala. Public Health Action 2013; 3 (Suppl 1): S38-S42.
28. Tabarsi P, Baghaei P, Marjani M, Vollmer W M, Masjedi M R, Harries A D. Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study. J Diabetes Metab Disord 2014; 13: 123.
29. Kumpatla S, Aravindalochanan V, Rajan R, Viswanathan V, Kapur A. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India. Diabetes Res Clin Pract 2013; 102: 60-64.
30. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101.
31. Adepoyibi T, Weigl B, Greb H, Neogi T, McGuire H. New screening technologies for type 2 diabetes mellitus appropriate for use in tuberculosis patients. Public Health Action 2013; 3 (Suppl 1): S10-S17.
32. World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. WHO/HTM/TB.2013.04. Geneva, Switzerland: WHO, 2013.
33. Lin Y, Li L, Mi F, et al. Screening of patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health 2012; 17: 1302-1308.
34. India Diabetes Mellitus-Tuberculosis Study Group. Screening of patients with diabetes mellitus for tuberculosis in India. Trop Med Int Health 2013; 18: 646-654.
35. Kumpatla S, Sekar A, Achanta S, et al. Characteristics of patients with diabetes screened for tuberculosis in a tertiary care hospital in South India. Public Health Action 2013; 3 (Suppl 1): S23-S28.
36. World Health Organization. Guidelines on the management of latent tuberculosis infection. WHO/HTM/TB/2015.01. Geneva, Switzerland: WHO, 2015.
37. Wang J-Y, Lee M-C, Shu C-C, et al. Optimal duration of anti-TB treatment in patients with diabetes-nine or six months? Chest 2015; 147: 520-528.
38. Singhal A, Jie L, Kumar P, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med 2014; 6: 263ra159.
39. Harries A D, Lin Y, Satyanarayana S, et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 2011; 15: 1436-1444.
40. Allain T J, van Oosterhout J J, Douglas G P, et al. Applying lessons learnt from the 'DOTS' tuberculosis model to monitoring and evaluating persons with diabetes mellitus in Blantyre, Malawi. Trop Med Int Health 2011; 16: 1077-1084.
41. Khader A, Ballout G, Shahin Y, et al. Diabetes mellitus and treatment outcomes in Palestine refugees in UNRWA primary health care clinics in Jordan. Public Health Action 2014; 3: 259-264.